News | Women's Health | May 11, 2017

Global market research gives insight to the competitive mammography landscape

mammography exam

Photo courtesy of Hologic


Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer Society, one in every nine women is expected to develop breast cancer in her lifetime, and one in thirty will die from it. Though breast cancer rates were high relatively high in the 1990s, they decreased in the 2000s—and continue to remain much lower than they were in the 80s and 90s—thanks to the increased use of mammography. Mammography can detect early breast cancer in women experiencing no symptoms and is an essential tool and lifesaving measure. According to Infiniti Research, the global market for mammography devices and equipment will grow at a rate of more than 9 percent until 2020.

Infiniti Research has recently completed a market assessment on the mammography device market for a leading global manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products. The purpose of this study was to help the client assess and analyze the competitive landscape for mammography devices.

 

Market Trends

Though 2-D mammography has long been an effective and affordable industry standard, 3-D mammography is becoming more popular. While 2-D mammography captures two static images of the breast, 3-D mammography takes multiple images of the breast, allowing for a more comprehensive and accurate picture, and reducing the risk of missing abnormalities due to image overlap. However, the benefits of 3-D mammography over 2-D have yet to be fully proven, and 3-D mammography is more expensive for uninsured patients. Another popular method involves combining 2-D and 3-D mammography, though this is currently very new. Some studies have suggested that 3-D mammography puts the patient at a higher risk for cancer from radiation, though this has not yet been confirmed.

 

Market Opportunities

Because the use of 3-D and combination 2-D and 3-D mammography is still relatively new and the risks associated with it are still largely unknown or unconfirmed, market intelligence is critical for vendors looking to enter this market. To keep their patients safe and establish themselves as reliable, vendors need to be up-to-date on market trends and developments, medical advancements and challenges, and how breast cancer incidence and treatment differs around the world.

In their latest assessment of the global mammography device market, Infiniti’s market intelligence analysts helped their client, a leading global manufacturer and supplier of diagnostic products, to gain an in-depth understanding of how the competitive landscape for mammography devices and equipment differed across the world, with special focus on target countries including the US, Germany, China, Great Britain, Australia, and France. Infiniti’s analysts researched and monitored the latest developments in the market through journals and whitepapers, and also conducted extensive interviews with stakeholders such as channel partners, business executives, and suppliers in order to develop a holistic overview of the market scenario.

 

You can view the complete study here: https://www.infinitiresearch.com/casestudy/competitive-intelligence-assessment-mammography-devices


Related Content

News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
Subscribe Now